A new diabetes drug is effective in lowering blood sugar, shows much lower risk of hypoglycemia

A new type 2 diabetes treatment has been shown effective in a new study led by the University of Michigan. TAK-875, was found to be equally as effective as a current type 2 diabetes treatment, glimepiride, at improving glucose control, but also has shown a much lower risk of creating a dangerous drop in blood sugar known as hypoglycemia. The new oral medication is designed to increase insulin secretion in a glucose-dependent method, so that when glucose levels are normal, it has no effects on insulin production. In the study, there was a 19 percent incident of hypoglycemia in patients treated with glimepiride, while the incidence was only 2 percent in those who were given TAK-875, the same percentage as placebo. “We are truly excited about the potential of TAK-875 and are eager to conduct larger trials to find out how well this drug works, how safe it is and what its place is in the treatment of diabetes,” the authors of the study concluded.